BRCA1 and breast cancer: For this reason, in this study we aimed to evaluate the effect(s) of oral DHA supplementation on plasma resolvin D1 and D2 levels in BC patients compared to controls and to verify differences in their concentrations according to the type of disease presentation (sporadic, familial, or BRCA1/2-mutated) and immunohistochemical characteristics.